ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Astragaloside Iv

Also known as: Astragaloside-A, AS-IV, Astragaloside IV

Overview

Astragaloside IV (ASIV) is a triterpenoid saponin derived from the root of *Astragalus membranaceus*, a plant prominent in traditional Chinese medicine. This bioactive compound is renowned for its antioxidant, anti-inflammatory, and anti-apoptotic properties, with research highlighting its potential benefits in cardiovascular protection and renal health. Preclinical studies demonstrate its ability to reduce myocardial infarct size and improve renal markers in diabetic nephropathy. While extensive research in animal models underscores its efficacy, human clinical trials are limited, thus necessitating further investigation to validate its therapeutic potential in human populations. ASIV can be administered in extract form and is sought for its health-promoting effects.

Benefits

Astragaloside IV has demonstrated several evidence-based benefits, including significant cardiovascular protection, where animal studies show decreased myocardial infarct sizes and improved cardiac function. Additionally, it has potential renal protective effects, evidenced by reduced serum creatinine and blood urea nitrogen in diabetic nephropathy models. Secondary benefits include notable anti-inflammatory and antioxidant actions that bolster its protective mechanisms. Although these findings are promising, the effectiveness in human populations remains to be conclusively established. The studies exhibit notable strengths within controlled animal models but highlight a critical gap in human clinical data, calling for further investigation.

How it works

Astragaloside IV operates through various biological pathways, presenting anti-inflammatory, antioxidant, anti-apoptotic, and anti-fibrotic properties. It primarily interacts with cardiovascular and renal systems, influencing signaling pathways associated with inflammation and oxidative stress. While exact molecular targets are not fully elucidated, ASIV has been shown to mitigate cellular damage and promote resilience in health crises encountered by these systems.

Side effects

The safety profile of Astragaloside IV has been primarily assessed through preclinical studies, where it is generally considered safe, but comprehensive human safety data is limited. Common side effects are not well-documented, but potential interactions with cardiovascular drugs may elevate concerns regarding blood pressure and cardiac function. No established contraindications exist, and caution is advised during pregnancy and lactation due to insufficient data. Overall, further research into its side effects and drug interactions in human populations is warranted to establish clear guidelines.

Dosage

Dosage recommendations for Astragaloside IV have not been established in humans. Preclinical studies suggest effective dosages ranging in milligrams per kilogram but do not specify optimal dosing for human use. There are no defined upper limits or safety thresholds available. Typically administered as an extract, bioavailability may be influenced by the formulation used. Since timing considerations for dosing remain unspecified, any prospective human use should approach caution and base decisions on emerging clinical data.

FAQs

Is Astragaloside IV safe for human consumption?

While generally safe in animal studies, the lack of comprehensive human trials raises caution. It's advised to approach its use judiciously.

What are the potential benefits of Astragaloside IV?

ASIV may offer cardiovascular and renal protective benefits, particularly for those with specific conditions, but human efficacy remains to be fully confirmed.

How should I take Astragaloside IV?

There are no specific guidelines for human intake; typically, it is provided as an extract. Consult healthcare providers for personal recommendations.

Can Astragaloside IV interact with my medications?

Yes, potential interactions with cardiovascular medications exist. Always discuss with a healthcare provider before starting ASIV, especially if on other treatments.

Why is there limited human research on Astragaloside IV?

Most studies are preclinical, focusing on animal models, with insufficient data from human trials to confirm safety and effectiveness.

Research Sources

  • https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1226008/full – This study dives into the cardioprotective effects of ASIV, highlighting its capability to improve cardiac function in animal models of heart failure. It emphasizes the need for more human-based research to substantiate these findings.
  • https://pubmed.ncbi.nlm.nih.gov/32942018/ – This meta-analysis reviews the renal protective effects of ASIV, noting significant reductions in kidney damage markers in experimental models of diabetic nephropathy, reinforcing its potential therapeutic targets.
  • https://pubmed.ncbi.nlm.nih.gov/30018562/ – The study discusses the impact of ASIV on myocardial ischemia/reperfusion injury, demonstrating a decrease in myocardial infarct size and improved cardiac outcomes in relevant animal studies, stressing the need for human trials.